Genestra Brands TM Femagen PMS Tablets
Genestra Brands TM Femagen PMS Tablets, NPN 80038623: natural health product licensed in Canada. Medicinal ingredients: Vitamine B6, Dioscorea villosa, Bos taurus, Folate.
If this product were sold in France
- Declared dose above a limit
Vitamine B6: up to 100 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- To check
Vitamine B6: up to 100 mg a day according to the dosing instructions published by Health Canada, above the tolerable upper intake level from EFSAEuropean Food Safety Authority. for adults (12 mg a day). The EFSA reference covers total daily intake, from food and supplements.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- Legal conditions
Dioscorea villosa L.: Les matières premières végétales doivent avoir subi les étapes traditionnelles d'épluchage, de lavage et de traitement thermique. L'absence d'alcaloïdes et de composés cyanogènes doit être démontrée par des bulletins d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 50 mg | 100,000 µg |
| Dioscorea villosa Source : Racine | 10 mg | Not calculated |
| Bos taurus Source : Adrenal | 25 mg | Not calculated |
| Folate Source : Acide folique | 150 mcg | Not calculated |
| bêta-carotène Source : bêta-carotène Potency : 2,000 UI | 1,200 mcg | Not calculated |
| Taraxacum officinale Source : Feuille | 10 mg | Not calculated |
| Caulophyllum thalictroides Source : Racine | 15 mg | Not calculated |
Non-medicinal ingredients
Acide stéarique, Dioxyde de silicium, Stéarate de magnésium, Cellulose, microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe féminin | Not specified | 1 Comprimé | 2 Tous les jours |
Uses authorised in Canada
A factor in the maintenance of good health. Helps to relieve symptoms associated with premenstrual syndrome. A source of vitamin A to help maintain eyesight, skin, membranes and immune function; helps in the development and maintenance of bones and teeth; helps the body to metabolize carbohydrates, fats and proteins; helps normal growth; helps in tissue formation; helps to form red blood cells and helps in their proper function and helps to maintain proper muscle function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Cautions and Warnings
Consult your health care practitioner prior to use. If you have diabetes, angina, high blood pressure or if you are taking blood thinner medication, consult your health care practitioner prior to use.
- Contra-Indications
If you are pregnant or breastfeeding; if you have liver, vascular or gastrointestinal diseases, gallbladder inflammation, hyperpituitarism, hyperadrenia, or bile duct obstruction; or if you have or have had breast, uterine, or ovarian cancer or are taking oral contraceptive medication, do not use.
- Known Adverse Reactions
People sensitive to nicotinic acid may experience flushing of the skin that is generally mild and transient.
Product record
- Licence holder
- Seroyal International
- NPN or DIN-HM
- 80038623
- Status
- Active licence
- Licence date
- 10 January 2013
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80038623
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Genestra Brands TM Femagen PMS Tablets (Seroyal International): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80038623-genestra-brands-tm-femagen-pms-tablets, updated 10 January 2013.